REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinphar Pharmaceutical Co., Ltd. (Taiwan, China)

Main Activities: Chemical Manufacturing | Medicinal and Botanical Manufacturing
Full name: Sinphar Pharmaceutical Co., Ltd. Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Sinphar Pharmaceutical Co., Ltd. was established on July 2 1977 and listed in OTC on October 17, 2000. In January 203 the company received ISO-9001 quality certification through Bureau of Commodity Inspection, the Ministry of Economic Affairs. The company is principally engaged in the manufacture and distribution of pharmaceuticals, functional food products, medical equipment and cosmetics. The company provides pharmaceuticals, including capsules, soft capsules, granules, oral liquids, injections, ointments and eye drops, such as Mentax Cream, Phyxol Injection and Sinphar Taminace Nutritional Capsules, as well as functional food products, medical equipment and cosmetics. During the year ended 2010, the company obtained approximately 58.79% and 34.72% of its total revenue from pharmaceuticals and functional food products, respectively.

Headquarters
84 Chung Shan Village, Tung-Shan Shine
I-Lan;

Contact Details: Purchase the Sinphar Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.sinphar.com

Basic Information
Total Employees:
Purchase the Sinphar Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Sinphar Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Sinphar Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
July 02, 1977
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Assistant Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
9.22%
Purchase this report to view the information.
1.88%
Purchase this report to view the information.
0.94%
Purchase this report to view the information.
0.89%
Purchase this report to view the information.
0.8%
Subsidiaries
Universalnext Technologies Inc.
100%
杏力醫療器材生技股份有限公司
100%
Cancap Pharmaceutical Ltd.
88.43%
Company Performance
Financial values in the chart are available after Sinphar Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
3.21%
Total operating revenue
3.7%
Operating profit (EBIT)
32.28%
EBITDA
7.37%
Net Profit (Loss) for the Period
-2%
Total assets
7.17%
Total equity
7%
Operating Profit Margin (ROS)
2.23%
Net Profit Margin
-0.57%
Return on Equity (ROE)
-0.44%
Debt to Equity Ratio
3.58%
Quick Ratio
0.09%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?